Prof Dr A.J. Boon

van Alfen, N., Doorduin, J., van Rosmalen, M. H. J., van Eijk, J. J. J., Heijdra, Y., Boon, A. J., Gaytant, M. A., van den Biggelaar, R. J. M., Sprooten, R. T. M., Wijkstra, P. J., & Groothuis, J. T. (2018). Phrenic neuropathy and diaphragm dysfunction in neuralgic amyotrophy. Neurology, 91(9), E843-E849. https://doi.org/10.1212/WNL.0000000000006076

Aarts, S. A. B. M., Seijkens, T. T. P., Kusters, P. J. H., van der Pol, S. M. A., Zarzycka, B., Heijnen, P. D. A. M., Beckers, L., den Toom, M., Gijbels, M. J. J., Boon, L., Weber, C., de Vries, H. E., Nicolaes, G. A. F., Dijkstra, C. D., Kooij, G., & Lutgens, E. (2017). Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation. Journal of Neuroinflammation, 14(1), Article 105. https://doi.org/10.1186/s12974-017-0875-9

Wolf, D., Bukosza, N., Enge, D., Poggi, M., Jehle, F., Michel, N. A., Chen, Y.-C., Colberg, C., Hoppe, N., Dufner, B., Boon, L., Blankenbach, H., Hilgendorf, I., Muhlen, C. V. Z., Reinoehl, J., Sommer, B., Marchini, T., Febbraio, M. A., Weber, C., ... Zirlik, A. (2017). Inflammation, but not recruitment, of adipose tissue macrophages requires signalling through Mac-1 (CD11b/CD18) in diet-induced obesity (DIO). Thrombosis and Haemostasis, 117(2), 325-338. https://doi.org/10.1160/TH16-07-0553

van den Boogaard, F. E., van Gisbergen, K. P. J. M., Vernooy, J. H., Medema, J. P., Roelofs, J. J. T. H., van Zoelen, M. A. D., Endeman, H., Biesma, D. H., Boon, L., van't Veer, C., de Vos, A. F., & van der Poll, T. (2016). Granzyme A impairs host defense during Streptococcus pneumoniae pneumonia. American Journal of Physiology-Lung Cellular and Molecular Physiology, 311(2), L507-L516. https://doi.org/10.1152/ajplung.00116.2016

Chatzigeorgiou, A., Seijkens, T., Zarzycka, B., Engel, D., Poggi, M., van den Berg, S., van den Berg, S., Soehnlein, O., Winkels, H., Beckers, L., Lievens, D., Driessen, A., Kusters, P., Biessen, E., Garcia-Martin, R., Klotzsche-von Ameln, A., Gijbels, M., Noelle, R., Boon, L., ... Lutgens, E. (2014). Correction for Chatzigeorgiou et al., Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance (vol 111, pg 2686, 2014). Proceedings of the National Academy of Sciences of the United States of America, 111(12), 4644-4644. https://doi.org/10.1073/pnas.1403231111

Chatzigeorgioua, A., Seijkens, T., Zarzycka, B., Engel, D., Poggi, M., van den Berg, S., van den Berg, S., Soehnlein, O., Winkels, H., Beckers, L., Lievens, D., Driessen, A., Kusters, P., Biessen, E., Garcia-Martin, R., Ameln, A. K., Gijbels, M., Noelle, R., Boon, L., ... Lutgens, E. (2014). Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance. Proceedings of the National Academy of Sciences of the United States of America, 111(7), 2686-2691. https://doi.org/10.1073/pnas.1400419111